Myricetin Inhibits SARS-CoV-2 Viral Replication by Targeting M(pro) and Ameliorates Pulmonary Inflammation

The coronavirus disease 2019 (COVID-19) has spread widely around the world and has seriously affected the human health of tens of millions of people. In view of lacking anti-virus drugs target to SARS-CoV-2, there is an urgent need to develop effective new drugs. In this study, we reported our disco...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Front Pharmacol
Auteurs principaux: Xiao, Ting, Cui, Mengqi, Zheng, Caijuan, Wang, Ming, Sun, Ronghao, Gao, Dandi, Bao, Jiali, Ren, Shanfa, Yang, Bo, Lin, Jianping, Li, Xiaoping, Li, Dongmei, Yang, Cheng, Zhou, Honggang
Format: Artigo
Langue:Inglês
Publié: Frontiers Media S.A. 2021
Sujets:
Pharmacology
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC8248548/
https://ncbi.nlm.nih.gov/pubmed/34220507
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2021.669642
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires